Featured Research

from universities, journals, and other organizations

African-Americans bear disproportionate burden of smoking costs in California, study finds

Date:
January 13, 2010
Source:
University of California - San Francisco
Summary:
African Americans comprise six percent of the California adult population, yet they account for over eight percent of the state's smoking-attributable health-care expenditures and 13 percent of smoking-attributable mortality costs, according to a new analysis.

African Americans comprise six percent of the California adult population, yet they account for over eight percent of the state's smoking-attributable health care expenditures and 13 percent of smoking-attributable mortality costs, according to a new analysis by UCSF researchers.

In order to provide an objective picture of the disproportionate economic burden of tobacco use for African American Californians, the UCSF team assessed data from 2002, including health care costs related to smoking and productivity losses from smoking-caused mortality. Study findings are published in the January 2010 issue of the "American Journal of Public Health."

"California has one of the most comprehensive tobacco control programs in the world, and smoking prevalence in the state has been declining steadily as a result. However, not all Californians have benefited equally from these efforts," said lead author Wendy Max, PhD, professor-in-residence of health economics and co-director of the UCSF Institute for Health & Aging, School of Nursing. "Hopefully these data can be used to strengthen tobacco control programs and smoking cessation efforts throughout African American communities."

Researchers analyzed smoking-attributable costs for diseases, such as cancer and cardiovascular disease, for which incidence is identified in the 2004 US Surgeon General Report as causally related to cigarette smoking. They focused on expenditures for ambulatory care, prescription drugs, inpatient care, and home health care. The team also assessed smoking-attributable mortality for Californians aged 35 years and older using three measures: deaths, years of potential life lost, and productivity losses.

Findings include:

  • African Americans lose more years (16.3) of life per death than other Californians (12.5 years) due to smoking-attributable causes. A total of 3013 African American Californians died of smoking-attributable illness in 2002, representing a loss of over 49,000 years of life and $784 million in productivity.
  • Adult smoking prevalence in 2002 for African Americans was 19.3 percent compared with 15.4 percent for all Californians.
  • The total cost of smoking for the African American community amounted to $1.4 billion in 2002, or $1.8 billion in 2008 dollars.

"It is clear that we need to tailor more tobacco control programs to African Americans in California," said Max. "In addition, there exists a long history of tobacco industry promotions and economic support targeted to certain ethnic groups, particularly African Americans and Hispanics. I would encourage these communities to carefully consider the benefits of such programs in light of the tremendous economic and human costs."

The study included a national advisory panel of members of African American and Hispanic community organizations. Panelists advised the study team on the application of research models and are helping disseminate findings throughout California communities.

Co-authors are Hai-Yen Sung, PhD; Lue-Yen Tucker, BA; and Brad Stark, BA; all with the UCSF Institute for Health & Aging, School of Nursing at the time of the study. The research was supported by funds from the Tobacco-Related Disease Research Program of the University of California.


Story Source:

The above story is based on materials provided by University of California - San Francisco. Note: Materials may be edited for content and length.


Cite This Page:

University of California - San Francisco. "African-Americans bear disproportionate burden of smoking costs in California, study finds." ScienceDaily. ScienceDaily, 13 January 2010. <www.sciencedaily.com/releases/2010/01/100113172302.htm>.
University of California - San Francisco. (2010, January 13). African-Americans bear disproportionate burden of smoking costs in California, study finds. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/01/100113172302.htm
University of California - San Francisco. "African-Americans bear disproportionate burden of smoking costs in California, study finds." ScienceDaily. www.sciencedaily.com/releases/2010/01/100113172302.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins